Skip to main content

Table 3 Multivariate analysis results of factors affecting survival

From: Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients

 

OS

LRFFS

DMFS

HR (95%CI)

p

HR (95%CI)

p

HR (95%CI)

p

Kadish stage

C vs A/B

1.610

(0.582–4.453)

.358

1.436

(0.400–5.152)

.579

0.663

(0.177–2.483)

.541

LN

Y/N

1.581

(0.853–2.931)

.145

1.024

(0.467–2.247)

.952

2.781

(1.320–5.861)

.007

Orbital invasion

Y/N

1.505

(0.775–2.926)

.228

1.567

(0.660–3.718)

.309

2.434

(0.978–6.060)

.056

Treatment

 

.007

 

.007

 

.071

CCRTvsRT/S

0.644

(0.277–1.498)

.307

0.595

(0.217–1.632)

.313

0.985

(0.402–2.410)

.973

S + CCRTvsRT/S

0.168

(0.058–0.487)

.001

0.209

(0.069–0.633)

.006

0.145

(0.033–0.633)

.010

S + RTvsRT/S

0.511

(0.264–0.991)

.047

0.268

(0.106–0.681)

.006

0.673

(0.285–1.591)

.367

CCRTvsRT/S

0.644

(0.277–1.498)

.307

0.595

(0.217–1.632)

.313

0.985

(0.402–2.410)

.973

  1. LN lymph node, S surgery, CCRT Concurrent chemoradiotherapy, RT/S radiotherapy and surgery alone
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us